Key regions: United States, China, Germany, Japan, Europe
The Pharmacies market in CIS is experiencing significant growth due to several factors. Customer preferences for convenient and accessible healthcare services, as well as the increasing demand for over-the-counter medications, are driving this trend. Additionally, local special circumstances, such as the aging population and the rising prevalence of chronic diseases, are contributing to the development of the market. Furthermore, underlying macroeconomic factors, such as increasing disposable incomes and government initiatives to improve healthcare infrastructure, are also fueling the growth of the Pharmacies market in CIS. Customer preferences in the Pharmacies market in CIS are shifting towards convenience and accessibility. With busy lifestyles and limited time, customers prefer to have easy access to healthcare services. Pharmacies provide a convenient solution by offering a range of products and services in one location. Customers can easily purchase over-the-counter medications, receive advice from pharmacists, and access basic healthcare services without the need for a doctor's appointment. This convenience factor is driving the growth of the Pharmacies market in CIS. Another customer preference driving the growth of the Pharmacies market in CIS is the increasing demand for over-the-counter medications. As people become more health-conscious and proactive in managing their health, they are seeking self-care options. Over-the-counter medications offer a convenient and affordable solution for common ailments and minor health issues. Pharmacies provide a wide range of over-the-counter medications, making them a preferred choice for customers seeking self-care options. Trends in the Pharmacies market in CIS include the expansion of pharmacy chains and the adoption of digital technologies. Pharmacy chains are expanding their presence in the region to cater to the growing demand for healthcare services. This expansion allows them to reach a wider customer base and provide a consistent level of service across multiple locations. Additionally, pharmacies are adopting digital technologies to enhance the customer experience. Online ordering and delivery services, as well as digital health platforms, are becoming increasingly common in the Pharmacies market in CIS. Local special circumstances in the CIS region, such as the aging population and the rising prevalence of chronic diseases, are contributing to the growth of the Pharmacies market. As the population ages, there is a greater need for healthcare services, including medication management and health advice. Pharmacies play a crucial role in meeting these needs by providing accessible healthcare services and personalized advice. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases, creates a demand for ongoing medication and healthcare support, which pharmacies can provide. Underlying macroeconomic factors, such as increasing disposable incomes and government initiatives to improve healthcare infrastructure, are also driving the growth of the Pharmacies market in CIS. Rising disposable incomes enable people to spend more on healthcare products and services, including medications. Government initiatives aimed at improving healthcare infrastructure, such as the development of primary healthcare centers and the expansion of healthcare coverage, create opportunities for pharmacies to expand their services and reach a larger customer base. Overall, the Pharmacies market in CIS is developing due to customer preferences for convenience and accessibility, increasing demand for over-the-counter medications, local special circumstances such as an aging population and rising prevalence of chronic diseases, and underlying macroeconomic factors such as increasing disposable incomes and government initiatives to improve healthcare infrastructure. These factors are driving the growth of the Pharmacies market and creating opportunities for both local and international players in the region.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
